Condition

Low Risk Prostate Cancer clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Low Risk Prostate Cancer clinical trials that are recruiting, at sites in 3 countries (most in Turkey (Türkiye) (1), United Kingdom (1), Italy (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Low Risk Prostate Cancer clinical trials

StudyPhaseWhereStatusRegistered
Using PSMA PET/CT imaging to help choose which men with low-risk prostate cancer can enter active surveillance — Istanbul, Turkey and 9 other locations Recruiting Sep 11, 2025
Identifying risks in low-risk prostate cancer patients on active surveillance — Milan, Italy Recruiting Mar 10, 2025
Reducing prostate cancer treatment from 5 to 3 doses of radiotherapy — Edinburgh Recruiting Nov 3, 2023

All recruiting trials (3)

Related topics

Clinically Significant Prostate CancerLocalized Prostate Cancer

Quick answers

How many Low Risk Prostate Cancer clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Turkey (Türkiye) (1 trial), United Kingdom (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.